CA2957762C - Compositions de promédicament d’aripiprazole - Google Patents

Compositions de promédicament d’aripiprazole

Info

Publication number
CA2957762C
CA2957762C CA2957762A CA2957762A CA2957762C CA 2957762 C CA2957762 C CA 2957762C CA 2957762 A CA2957762 A CA 2957762A CA 2957762 A CA2957762 A CA 2957762A CA 2957762 C CA2957762 C CA 2957762C
Authority
CA
Canada
Prior art keywords
composition
aripiprazole
less
particles
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2957762A
Other languages
English (en)
Other versions
CA2957762A1 (fr
Inventor
Philip Cresswell
Magali Hickey
Elaine Liversidge
David Manser
Jr. Palmieri Michael
Sara Montminy Paquette
Kristopher Perkin
Greg Smith
Brian Steinberg
Ryan Turncliff
Tarek Zeidan
Ethan P. Cash
Marjie L. Hard
Original Assignee
Alkermes Pharma Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alkermes Pharma Ireland Ltd filed Critical Alkermes Pharma Ireland Ltd
Priority claimed from PCT/EP2015/068872 external-priority patent/WO2016026822A1/fr
Publication of CA2957762A1 publication Critical patent/CA2957762A1/fr
Application granted granted Critical
Publication of CA2957762C publication Critical patent/CA2957762C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L’invention concerne une composition comprenant (a) une population de particules d’un promédicament d’aripiprazole ayant une taille de particule en volume (Dv50) inférieure à 1 000 nm et (b) au moins un stabilisant de surface comprenant un composant absorbé qui est absorbé sur la surface des particules de promédicament d’aripiprazole et un composant libre disponible pour la solubilisation du promédicament d’aripiprazole. Le rapport stabilisant de surface au promédicament permet d’obtenir la quantité optimale de stabilisant de surface libre à des fins de production d’une formulation d’entrée. L’invention concerne également des procédés de traitement employant la composition susmentionnée.
CA2957762A 2014-08-18 2015-08-17 Compositions de promédicament d’aripiprazole Active CA2957762C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462038665P 2014-08-18 2014-08-18
EP14181328 2014-08-18
US62/038,665 2014-08-18
EP14181328.7 2014-08-18
PCT/EP2015/068872 WO2016026822A1 (fr) 2014-08-18 2015-08-17 Compositions de promédicament d'aripiprazole

Publications (2)

Publication Number Publication Date
CA2957762A1 CA2957762A1 (fr) 2016-02-25
CA2957762C true CA2957762C (fr) 2025-10-07

Family

ID=

Similar Documents

Publication Publication Date Title
US11154552B2 (en) Aripiprazole prodrug composition
US20220079939A1 (en) Aripiprazole prodrug composition
JP7157830B2 (ja) アリピプラゾールプロドラッグ組成物
EP3416616B1 (fr) Compositions de promédicaments d'aripiprazole multiples
CA2957762C (fr) Compositions de promédicament d’aripiprazole
RU2817019C2 (ru) Композиции пролекарства арипипразола
HK40049829A (en) Aripiprazole prodrug compositions
HK40049829B (zh) 阿立哌唑前体药物组合物
HK1235285B (en) Aripiprazole prodrug compositions
HK1235285A1 (en) Aripiprazole prodrug compositions